The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis
Abstract
Although the median survival for patients with cystic fibrosis (CF) is 32.9 years, a small group of patients live much longer. We analyzed the genotype and phenotype of CF patients 40 years and older seen between 1992 and 2004 at the National Jewish Medical and Research Center (n = 55). These patients were divided into two groups according to age at diagnosis: an early diagnosis (ED) group, median age at diagnosis 2.0 years (range 0.1-15 years, n = 28), and a late diagnosis (LD) group, median age of diagnosis 48.8 years (range 24-72.8 years, n = 27). Consistent with the hypothesis that the CFTR genotype affects the age at diagnosis, CFTR DeltaF508 homozygous individuals were more common in the ED group. Although patients in the ED group were predominantly male, the majority of LD patients were female. Patients with CF diagnosed late had a significantly lower prevalence of pancreatic insufficiency and CF-related diabetes, and better lung function. Fewer patients in the LD groups were infected with Pseudomonas aeruginosa, whereas a greater percentage had cultures positive for nontuberculous mycobacteria. This is the largest cohort of older patients with CF described to date, and our findings indicate that patients diagnosed as adults differ distinctly from survivors of long-term CF diagnosed as children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311503 · Cited by 441
Cited by
Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment
Falkinham, III (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04161.x · Cited by 561
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Rowe, S. M., Daines, C., Ringshausen, F. C., Kerem, E., Wilson, J., Tullis, E., Nair, N., Simard, C., Han, L., Ingenito, E. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709847 · Cited by 522
Floto, R. A., Olivier, K. N., Saiman, L., Daley, C. L., Herrmann, J.-L., Nick, J. A., Noone, P. G., Bilton, D., Corris, P., Gibson, R. L., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207360 · Cited by 466
Self-citationFloto, R. A., Olivier, K. N., Saiman, L., Daley, C. L., Herrmann, J.-L., Nick, J. A., Noone, P. G., Bilton, D., Corris, P., Gibson, R. L., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207983 · Cited by 462
Self-citation
Metadata
- Authors
- Rodman, D. M., Polis, J. M., Heltshe, S. L., Sontag, M. K., Chacon, C., Rodman, R. V., Brayshaw, S. J., Huitt, G. A., Iseman, M. D., Saavedra, M. T., Taussig, L. M., Wagener, J. S., Accurso, F. J., & Nick, J. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-15
- Volume
- 171
- Issue
- 6
- Pages
- 621-626
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2119683141
- Cited by
- 160
- References
- 1
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.200403-404oc
- The paper
- Rodman, D. M., Polis, J. M., Heltshe, S. L., Sontag, M. K., Chacon, C., Rodman, R. V., Brayshaw, S. J., Huitt, G. A., Iseman, M. D., Saavedra, M. T., Taussig, L. M., Wagener, J. S., Accurso, F. J., & Nick, J. A. (2005). Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200403-404oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.